Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Oikonomakos, Nikos G.
Schnier, Joachim B.
Zographos, Spyros E.
Skamnaki, Vicky T.
Tsitsanou, Katerina E.
and
Johnson, Louise N.
2000.
Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor Site.
Journal of Biological Chemistry,
Vol. 275,
Issue. 44,
p.
34566.
Tsitsanou, Katerina E.
Skamnaki, Vicky T.
and
Oikonomakos, Nikos G.
2000.
Structural Basis of the Synergistic Inhibition of Glycogen Phosphorylase a by Caffeine and a Potential Antidiabetic Drug.
Archives of Biochemistry and Biophysics,
Vol. 384,
Issue. 2,
p.
245.
Treadway, Judith L
Mendys, Phil
and
Hoover, Dennis J
2001.
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Expert Opinion on Investigational Drugs,
Vol. 10,
Issue. 3,
p.
439.
Aiston, Susan
Hampson, Laura
Gómez-Foix, Anna M.
Guinovart, Joan J.
and
Agius, Loranne
2001.
Hepatic Glycogen Synthesis Is Highly Sensitive to Phosphorylase Activity.
Journal of Biological Chemistry,
Vol. 276,
Issue. 26,
p.
23858.
Mair, Johannes
2002.
Wiley Encyclopedia of Molecular Medicine.
Ekstrom, Jennifer L
Pauly, Thomas A
Carty, Maynard D
Soeller, Walter C
Culp, Jeff
Danley, Dennis E
Hoover, Dennis J
Treadway, Judith L
Gibbs, E.Michael
Fletterick, Robert J
Day, Yasmina S.N
Myszka, David G
and
Rath, Virginia L
2002.
Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase.
Chemistry & Biology,
Vol. 9,
Issue. 8,
p.
915.
Oikonomakos, Nikos G
Skamnaki, Vicky T
Ösz, Erzsébet
Szilágyi, László
Somsák, László
Docsa, Tibor
Tóth, Béla
and
Gergely, Pál
2002.
Kinetic and Crystallographic Studies of Glucopyranosylidene Spirothiohydantoin Binding to Glycogen Phosphorylase b.
Bioorganic & Medicinal Chemistry,
Vol. 10,
Issue. 2,
p.
261.
Oikonomakos, Nikos G.
Chrysina, Evangelia D.
Kosmopoulou, Magda N.
and
Leonidas, Demetres D.
2003.
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 Å resolution.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics,
Vol. 1647,
Issue. 1-2,
p.
325.
Bertsch, Martina
and
Kassner, Richard J.
2003.
Selective Staining of Proteins with Hydrophobic Surface Sites on a Native Electrophoretic Gel.
Journal of Proteome Research,
Vol. 2,
Issue. 5,
p.
469.
Ogawa, Anthony K.
Willoughby, Chris A.
Bergeron, Raynald
Ellsworth, Kenneth P.
Geissler, Wayne M.
Myers, Robert W.
Yao, Jun
Harris, Georgianna
and
Chapman, Kevin T.
2003.
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
Bioorganic & Medicinal Chemistry Letters,
Vol. 13,
Issue. 20,
p.
3405.
Kristiansen, Marit
Andersen, Birgitte
Iversen, Lars Fogh
and
Westergaard, Niels
2004.
Identification, Synthesis, and Characterization of New Glycogen Phosphorylase Inhibitors Binding to the Allosteric AMP Site.
Journal of Medicinal Chemistry,
Vol. 47,
Issue. 14,
p.
3537.
Kosmopoulou, Magda N.
Leonidas, Demetres D.
Chrysina, Evangelia D.
Bischler, Nicolas
Eisenbrand, Gerhard
Sakarellos, Constantinos E.
Pauptit, Richard
and
Oikonomakos, Nikos G.
2004.
Binding of the potential antitumour agent indirubin‐5‐sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b.
European Journal of Biochemistry,
Vol. 271,
Issue. 11,
p.
2280.
Deng, Qiaolin
Lu, Zhijian
Bohn, Joann
Ellsworth, Kenneth P.
Myers, Robert W.
Geissler, Wayne M.
Harris, Georgianna
Willoughby, Christopher A.
Chapman, Kevin
McKeever, Brian
and
Mosley, Ralph
2005.
Modeling aided design of potent glycogen phosphorylase inhibitors.
Journal of Molecular Graphics and Modelling,
Vol. 23,
Issue. 5,
p.
457.
Chrysina, Evangelia D.
Kosmopoulou, Magda N.
Kardakaris, Rozina
Bischler, Nicolas
Leonidas, Demetres D.
Kannan, Thanukrishnan
Loganathan, Duraikkannu
and
Oikonomakos, Nikos G.
2005.
Binding of β-d-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies.
Bioorganic & Medicinal Chemistry,
Vol. 13,
Issue. 3,
p.
765.
Prathipati, Philip
Pandey, Gyanendra
and
Saxena, Anil K.
2005.
CoMFA and Docking Studies on Glycogen Phosphorylase a Inhibitors as Antidiabetic Agents.
Journal of Chemical Information and Modeling,
Vol. 45,
Issue. 1,
p.
136.
Archontis, G.
Watson, K. A.
Xie, Q.
Andreou, G.
Chrysina, E. D.
Zographos, S. E.
Oikonomakos, N. G.
and
Karplus, M.
2005.
Glycogen phosphorylase inhibitors: A free energy perturbation analysis of glucopyranose spirohydantoin analogues.
Proteins: Structure, Function, and Bioinformatics,
Vol. 61,
Issue. 4,
p.
984.
Oikonomakos, Nikos G.
Kosmopoulou, Magda N.
Chrysina, Evangelia D.
Leonidas, Demetres D.
Kostas, Ioannis D.
Wendt, K. Ulrich
Klabunde, Thomas
and
Defossa, Elisabeth
2005.
Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
Protein Science,
Vol. 14,
Issue. 7,
p.
1760.
Lukacs, Christine M.
Oikonomakos, Nikos G.
Crowther, Robert L.
Hong, Li‐Na
Kammlott, R. Ursula
Levin, Wayne
Li, Shirley
Liu, Chao‐Min
Lucas‐McGady, Debra
Pietranico, Sherrie
and
Reik, Linda
2006.
The crystal structure of human muscle glycogen phosphorylase a with bound glucose and AMP: An intermediate conformation with T‐state and R‐state features.
Proteins: Structure, Function, and Bioinformatics,
Vol. 63,
Issue. 4,
p.
1123.
Agius, Loranne
2007.
New hepatic targets for glycaemic control in diabetes.
Best Practice & Research Clinical Endocrinology & Metabolism,
Vol. 21,
Issue. 4,
p.
587.
Gregus, Zoltán
and
Németi, Balázs
2007.
Glutathione-Dependent Reduction of Arsenate by Glycogen Phosphorylase—Responsiveness to Endogenous and Xenobiotic Inhibitors.
Toxicological Sciences,
Vol. 100,
Issue. 1,
p.
44.